Table 1 Clinical features of enrolled patients
|  | Bicuspid aortic stenosis (n = 33) | Tricuspid aortic stenosis (n = 24) | P-value |
|---|---|---|---|
Female, n (%) | 24 (72.73%) | 8 (33.33%) | 0.006 |
Age (years) | 72.48 ± 5.62 | 74.38 ± 5.53 | 0.21 |
Height (m) | 1.57 ± 0.08 | 1.61 ± 0.09 | 0.12 |
Weight (kg) | 55.15 ± 9.88 | 59.69 ± 9.87 | 0.92 |
BMI (kg/m2) | 22.13 ± 3.45 | 22.83 ± 3.23 | 0.44 |
STS-PROM (%) | 6.50 (4.42–8.59) | 8.26 (4.93–13.38) | 0.09 |
Comorbidities | |||
 Hypertension, n(%) | 15 (45.45%) | 7 (29.17%) | 0.27 |
 Diabetes, n (%) | 1 (3.03%) | 3 (12.5%) | 0.15 |
 Chronic lung disease, n (%) | 18 (54.55%) | 19 (79.17%) | 0.09 |
 Coronary artery disease, n (%) | 16 (48.48%) | 10 (41.67%) | 0.78 |
 Prior myocardial infarction, n (%) | 0 | 0 | – |
 Prior percutaneous coronary intervention, n (%) | 2 (6.06%) | 3 (12.5%) | 0.64 |
 Peripheral vascular disease, n (%) | 20 (60.60%) | 20 (83.3%) | 0.08 |
 Chronic kidney disease, n (%) | 6 (18.18%) | 5 (20.83%) | 0.99 |
Baseline echocardiography | |||
 Left ventricular ejection fraction, % | 53.73 ± 15.05 | 44.67 ± 14.19 | 0.025 |
 Transaortic Vmax, m/s | 5.14 ± 0.78 | 4.57 ± 0.85 | 0.011 |
 Transaortic PGmean, mmHg | 67.52 ± 21.99 | 55.79 ± 16.01 | 0.031 |
 LVM, g | 265.35 ± 87.38 | 338.84 ± 98.46 | 0.004 |
 LVMI, g/m2 | 161.66 ± 48.78 | 197.66 ± 62.32 | 0.018 |
 Ascending aorta diameter, mm | 40.50 ± 5.59 | 38.75 ± 4.32 | 0.21 |